dr. mitri on neratinib and pertuzumab in her2-amplified breast cancer
Published 6 years ago • 255 plays • Length 1:07Download video MP4
Download video MP3
Similar videos
-
1:49
dr. rahman on pertuzumab and neratinib in her2 breast cancer
-
2:18
use of neratinib in her2-positive breast cancer
-
0:53
eleanor: real-world study of extended adjuvant neratinib in her2 /hr early breast cancer
-
1:02
dr. mohammad jahanzeb on neratinib and trastuzumab in her2-positive breast cancer
-
2:00
dr. mitri on the treatment landscape of her2 breast cancer
-
1:13
dr. pegram discusses adjuvant pertuzumab in her2 breast cancer
-
1:14
dr. hamilton on how neratinib targets her2 breast cancer
-
1:09
dr. dang on neratinib in patients with her2 breast cancer
-
9:35
neratinib in her2 breast cancer
-
1:57
dr. dietrich on adverse event management for neratinib in breast cancer
-
1:37
dr. mitri discusses adjuvant therapy for her2 breast cancer
-
1:41
dr. traina discusses neratinib in her2 breast cancer
-
1:12
dr. nye on neratinib-associated diarrhea in her2 breast cancer
-
1:19
dr. pegram discusses the use of neratinib in her2 breast cancer
-
3:15
neratinib for metastatic breast cancer
-
1:53
optimal timing for neratinib
-
1:37
dr. traina on conversations on extended adjuvant therapy with neratinib in her2 breast cancer
-
1:58
dr. velez on managing neratinib-associated diarrhea in her2 breast cancer
-
4:09
her2 breast cancer: neratinib patient selection